Sakane Naoki, Domichi Masayuki, Suganuma Akiko
Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, 1-1Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto, 612-8555 Japan.
Diabetol Int. 2025 Apr 10;16(3):546-558. doi: 10.1007/s13340-025-00810-4. eCollection 2025 Jul.
BACKGROUND: Although carbohydrate counting (CC) being the recommended dietary strategy for achieving glycemic control in people with diabetes, there is limited evidence. Our aim is to systematically assess the efficacy of CC in people with diabetes. METHODS: We searched PubMed up to October 2024 and assessed randomized controlled trials of interventions longer than 12 weeks in people with diabetes. Change in glycated hemoglobin (HbA1c) levels was the primary outcome. The results of clinically and statistically homogenous studies were pooled and meta-analyzed using the random-effects model to provide estimates of the efficacy of CC. RESULTS: We identified 16 studies (633 children and 640 adults) in type 1 diabetes mellitus (T1DM) and 6 studies (966 adults) in type 2 diabetes mellitus (T2DM). There was significant improvement in HbA1c levels with CC versus the other diets in T1DM (- 0.21%, 95% CI - 0.41 to - 0.01; = 0.042) with large heterogeneity (I2 = 85.2%) in people with T1DM. In subgroup analyses, advanced CC (ACC) showed improved HbA1c levels (- 0.47%, 95% CI - 0.78 to - 0.15; = 0.004) in adults with T1DM, but ACC did not in children with T1DM (- 0.07%, 95% CI - 0.25 to 0.10; = 0.419). The effects of basic CC (BCC) on glycemic control for children with T1DM were not significant. Additionally, BCC did not show improved HbA1c levels in in adults with T2DM. CONCLUSIONS: For glycemic control in people with T1DM, CC was an effective option. Although BCC was not effective for glycemic control in adults with T2DM, further high-quality and long-term studies are needed to confirm these issues.
背景:尽管碳水化合物计数法(CC)是糖尿病患者实现血糖控制的推荐饮食策略,但相关证据有限。我们的目的是系统评估CC对糖尿病患者的疗效。 方法:检索截至2024年10月的PubMed,并评估糖尿病患者中干预时间超过12周的随机对照试验。糖化血红蛋白(HbA1c)水平的变化是主要结局。对临床和统计学上同质的研究结果进行汇总,并使用随机效应模型进行荟萃分析,以提供CC疗效的估计值。 结果:我们在1型糖尿病(T1DM)中确定了16项研究(633名儿童和640名成人),在2型糖尿病(T2DM)中确定了6项研究(966名成人)。与其他饮食相比,T1DM患者采用CC后HbA1c水平有显著改善(-0.21%,95%CI -0.41至-0.01;P = 0.042),但T1DM患者存在较大异质性(I2 = 85.2%)。在亚组分析中,成人T1DM患者采用强化碳水化合物计数法(ACC)后HbA1c水平有所改善(-0.47%,95%CI -0.78至-0.15;P = 0.004),但儿童T1DM患者采用ACC后HbA1c水平未改善(-0.07%,95%CI -0.25至0.10;P = 0.419)。基础碳水化合物计数法(BCC)对T1DM儿童血糖控制的效果不显著。此外,BCC在T2DM成人患者中未显示HbA1c水平改善。 结论:对于T1DM患者的血糖控制,CC是一种有效的选择。虽然BCC对T2DM成人患者的血糖控制无效,但需要进一步的高质量长期研究来证实这些问题。
Cochrane Database Syst Rev. 2021-4-19
Cochrane Database Syst Rev. 2017-9-27
Cochrane Database Syst Rev. 2020-1-9
Cochrane Database Syst Rev. 2012-12-12
Cochrane Database Syst Rev. 2017-12-22
Health Technol Assess. 2024-10
Cochrane Database Syst Rev. 2012-1-18
Cochrane Database Syst Rev. 2023-5-31
Ann Pediatr Endocrinol Metab. 2023-9
Front Clin Diabetes Healthc. 2023-8-29
Diabetes Technol Ther. 2023-9